Ivonescimab Plus Chemotherapy Demonstrates a Statistically Significant Benefit in Overall Survival with a Hazard Ratio of 0.74 in 2L+ Treatment of Patients with EGFRm NSCLC in HARMONi-A Study ...
The risk for dementia was more than 3 times greater among participants with both physical frailty and depression. HealthDay News — Individuals with physical frailty and depression have increased risk ...